| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/08/2004 | EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors |
| 09/08/2004 | CN1527838A Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 09/08/2004 | CN1527831A Antagonists of MCP-q function and method of use thereof |
| 09/08/2004 | CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes |
| 09/08/2004 | CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 09/08/2004 | CN1527820A 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 09/08/2004 | CN1527814A Nitric oxide synthase inhibitor phosphate salt |
| 09/08/2004 | CN1527813A ANtioxidant nitroxides and nitrones as therapeutic agents |
| 09/08/2004 | CN1527723A Methods for treating or preventing skin disorders using CD2-binding agents |
| 09/08/2004 | CN1527721A Compositions comprising mixtures of human cytokines and methods of producing the same |
| 09/08/2004 | CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
| 09/08/2004 | CN1527703A Pharmaceutical composition for preventing and treating cancer and treating an inflammation |
| 09/08/2004 | CN1527702A Nutritional supplements and methods of using same |
| 09/08/2004 | CN1526722A New taraxerol derivative and its prepn and use |
| 09/08/2004 | CN1526431A Chinese medicine for treating osteological diseases and its prepn process |
| 09/08/2004 | CN1526425A Acupoint injecting medicine liquid for treating femoral head necrosis |
| 09/08/2004 | CN1526424A Swelling eliminating and pain relieving plaster |
| 09/08/2004 | CN1526421A Prepn of single ingredient granule |
| 09/08/2004 | CN1526386A Houttuynin sodium powder injection and its prepn |
| 09/08/2004 | CN1165536C Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/08/2004 | CN1165329C Exterior-applied antalgic medicine and its preparing process |
| 09/08/2004 | CN1165328C New prepn process of Lideri ganula as one traditional Mongoliam medicine |
| 09/08/2004 | CN1165326C New prepn process of Zhuanglong granula as one traditional Mongolian medicine |
| 09/08/2004 | CN1165325C New prepn process of Manu as one traditional Mongolian medicine |
| 09/08/2004 | CN1165315C Remedies for joint diseases |
| 09/08/2004 | CN1165298C New use of compounds as antibacterial agents |
| 09/08/2004 | CN1165293C New oral formulation for 5-HT4 agonists or antagonists |
| 09/07/2004 | US6787672 1-(4-methoxyphenyl)-3-(3,5-dimethoxyphenyl)prop-1-en-3-one derivatives; antiproliferative and antiinflammatory agents |
| 09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
| 09/07/2004 | US6787571 Treating, preventing, or inhibiting diseases and disorders associated with inflammation, cell-proliferation |
| 09/07/2004 | US6787566 Breakers of advanced glycation endproducts |
| 09/07/2004 | US6787555 Such as 4-(4-fluorophenyl)-5-(2-phenylmethylamino)pyrimidin-4-yl)-1-ethoxymethyl -(1,2,3)triazole for inhibition of release of inflammatory interleukins; for treatment of osteoarthritis, rheumatoid arthritis, and congestive heart failure |
| 09/07/2004 | US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives |
| 09/07/2004 | US6787552 PPAR delta activators |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
| 09/07/2004 | US6787545 Secretory phospholipase a2 mediated fatty acid release |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/07/2004 | US6787539 2,4,5,-trisubstituted pyrimidine derivatives |
| 09/07/2004 | US6787536 Hydroxamic acid derivatives |
| 09/07/2004 | US6787534 Sulfonamide-containing heterocyclic compounds |
| 09/07/2004 | US6787532 Formulation containing anti-inflammatory androstane derivatives |
| 09/07/2004 | US6787346 Kinase capable of site-specific phosphorylation of IκBα |
| 09/07/2004 | US6787342 Paste formulations |
| 09/07/2004 | US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
| 09/07/2004 | CA2166898C Novel structural analogues of vitamin d |
| 09/03/2004 | CA2456410A1 Stabilised pharmaceutical composition comprising an extented release non-steroidal anti-inflammatory agent and an immediate release prostaglandin |
| 09/02/2004 | WO2004074345A2 Carbonate esters of polyethylene glycol activated by means of oxalate esters |
| 09/02/2004 | WO2004074316A1 Conformationally constrained backbone cyclized peptide analogs |
| 09/02/2004 | WO2004074297A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators |
| 09/02/2004 | WO2004074291A1 Triazole compounds useful in therapy |
| 09/02/2004 | WO2004074277A1 N-aryl- or n-heteroarylpiperazine derivative and medicine containing the same |
| 09/02/2004 | WO2004074271A1 Nitrate esters of phenylaminothiophenacetic acid derivatives |
| 09/02/2004 | WO2004074260A1 Pyrimidine derivatives |
| 09/02/2004 | WO2004074236A1 Novel transcriptional factor, process for producing the same and use thereof |
| 09/02/2004 | WO2004074224A1 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 09/02/2004 | WO2004074218A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/02/2004 | WO2004073733A1 Interleukin 6 production inhibitor |
| 09/02/2004 | WO2004073723A1 Medical drug containing fine particle of noble metal |
| 09/02/2004 | WO2004073704A1 New combination |
| 09/02/2004 | WO2004073628A2 Novel compounds |
| 09/02/2004 | WO2004073602A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 09/02/2004 | WO2004073593A2 Use of acylated aminopropanediols and sulphur and nitrogen analogues of same for different therapeutic applications |
| 09/02/2004 | WO2004073586A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor tg1019 (tg1019) |
| 09/02/2004 | WO2004060361A3 Combination of reboxetine and a cyclooxygenase-2 inhibitor |
| 09/02/2004 | WO2003084539A3 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 09/02/2004 | WO2003084344A3 Method of improving absorption of vitamin e by a pet animal |
| 09/02/2004 | WO2003049698A8 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
| 09/02/2004 | US20040172112 Methods for treating prostatitis |
| 09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/02/2004 | US20040171832 Novel sulfonate substituted pyrazol pyridine derivatives |
| 09/02/2004 | US20040171830 Carboline derivatives as pdev inhibitors |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171695 Guanylhydrazones useful for treating diseases associated with T cell activation |
| 09/02/2004 | US20040171676 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 09/02/2004 | US20040171666 Rapid, thorough absorption; eliminates gastrointestional disorder and reduces central nervous system stimulation side effects; low cost |
| 09/02/2004 | US20040171658 Blood coagulation factor Xa inhibition; such as 2-O-(3'-amidinobenzyl)-5-O-(3''-amidinophenyl)-1,4:3,6-dianhydrosorbitol |
| 09/02/2004 | US20040171654 Sulfur compounds such as 4-tert-Butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide, used as chemokine receptor antagonists, antiinflamatory agents or as immunology modulators |
| 09/02/2004 | US20040171641 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 09/02/2004 | US20040171639 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 09/02/2004 | US20040171623 thieno[2,3-d]pyrimidinediones; modulation of autoimmune disease |
| 09/02/2004 | US20040171618 Compounds as PDE IV and TNF-inhibitors |
| 09/02/2004 | US20040171617 treatment for disorders and diseases, such as chronic inflammation, tissue breakdown and cancer |
| 09/02/2004 | US20040171612 Novel compounds with analgesic effect |
| 09/02/2004 | US20040171607 Chemical compounds |
| 09/02/2004 | US20040171599 Use of a pharmaceutically acceptable cellulose derivative to inhibit or reduce crystal growth of ascomycin |
| 09/02/2004 | US20040171597 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 09/02/2004 | US20040171581 Polysaccharidic esters of retinoic acid |
| 09/02/2004 | US20040171557 treating or educating said cells ex vivo in the presence of: intermediary metabolite; antigens or epitopes associated with said disease, or the immune-mediated inflammatory response; re-administering to said subject said treated or educated cells |
| 09/02/2004 | US20040171549 Method of inhibiting angiogenesis or invasion or formation of metastases |
| 09/02/2004 | US20040171528 Raise intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171527 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 09/02/2004 | US20040171526 Raise intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171522 Raise the intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171122 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same |